Vanda Pharmaceuticals (VNDA) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

VNDA Vanda Pharmaceuticals

Watchlist

4.735
+0.175+3.84%

Trading Oct 31 14:06 ET

276.00MMarket Cap-24921P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Street Seen Sleeping on Sleep-Drug Maker Vanda -- Market Talk
WSJOct 31 11:53 ET
Vanda Pharma Analyst Ratings
BenzingaOct 31 07:59 ET · Ratings
H.C. Wainwright Initiates Vanda Pharmaceuticals(VNDA.US) With Buy Rating, Announces Target Price $18
Moomoo NewsOct 31 06:31 ET · Ratings
Express News | Vanda Pharmaceuticals Inc : H.c. Wainwright Initiates Coverage With Buy Rating; Target Price $18
ReutersOct 31 06:30 ET
Vanda Pharmaceuticals to Announce Third Quarter 2024 Financial Results on November 6, 2024
PR NewswireOct 30 16:30 ET
VNDA Rejects Second Takeover Bid by Cycle Group, Stock Rises
Zacks Oct 15 11:05 ET

Comments

1022711996

Oct 23 11:37

$Vanda Pharmaceuticals (VNDA.US)$ in 7 hrs time need close above 4.75

Teo knows

Oct 14 10:15

$Vanda Pharmaceuticals (VNDA.US)$ scam

Stock_Drift

Oct 14 10:08

$Vanda Pharmaceuticals (VNDA.US)$

Jaguar8

Oct 14 09:57

NEWS

$Vanda Pharmaceuticals (VNDA.US)$
Vanda Pharmaceuticals Confirms Receipt of Economically Identical Unsolicited, Non-Binding Proposal from Cycle Group Holdings Ltd.
Vanda Pharmaceuticals confirmed receipt of a second unsolicited, non-binding proposal from Cycle Group Holdings to acquire the company for $8.00 per share in cash. This proposal, received on September 23, 2024, is economically identical to the previously rejected offer from May 24, 2024.
Vanda's Board of Directors unanimously dete...